Moderna Inc. buy BMO Capital Markets
Start price
12.01.26
/
50%
€29.02
Target price
12.01.27
-
Performance (%)
21.40%
Price
09.02.26
€35.23
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets currently has a performance of 21.40%. This prediction currently runs until 12.01.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Moderna Inc. | -6.775% |
| iShares Core DAX® | 1.085% |
| iShares Nasdaq 100 | -1.665% |
| iShares Nikkei 225® | 3.863% |
| iShares S&P 500 | 0.111% |
Comments by BMO_Capital_Markets for this prediction
In the thread Moderna Inc. diskutieren
Moderna (NASDAQ:MRNA) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to a "buy" rating.
Ratings data for MRNA provided by MarketBeat